Important pharmacy news and late-breaking industry information updated daily.

As the influenza season gets under way in the United States, FDA has approved baloxavir marboxil (Xofluza—Shionogi & Co.) for the treatment of acute uncomplicated influenza in individuals aged 12 years and older who have been symptomatic for no more than 48 hours.

New law opens treatment pathways but doesn’t take full advantage of pharmacists’ expertise

FDA, working with international regulatory and law enforcement agencies, announced Tuesday it recently took steps to target nearly 500 websites that illegally sell potentially dangerous, unapproved prescription drugs to consumers. The initiative was part of Operation Pangea XI, the 11th annual International Internet Week of Action (IIWA).

Held October 21-24, 2018, in Kansas City, MO

JAMA Open study: Sexual enhancement, weight loss, and muscle-building products are biggest offenders

After a decades-long decline, the cardiovascular death rate has all but stalled and has even reversed in a young group of people—adults aged 35 to 64 years, among whom deaths from heart disease are now rising.

Other measures can be considered instead

Michael Hogue, president-elect of APhA—as well as the speaker of the APhA House of Delegates—says he is "extremely hopeful about the future of pharmacy and have some ideas of how we will get there, but first we have to help lift up our colleagues and move through a difficult period." The APhA House of Delegates in March adopted a policy

Data from new study suggest reasons for misuse and potential solutions

Purdue Pharma has asked counties suing the drug manufacturer for allegedly causing the opioid epidemic to offer specific details to back up their claims.